News
Chain-of-thought monitorability could improve generative AI safety by assessing how models come to their conclusions and ...
Google’s DeepMind and OpenAI, which makes ChatGPT, say they both achieved a gold medal-level performance at this year's ...
The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
On the early evening of June 22, 2010, American tennis star John Isner began a grueling Wimbledon match against Frenchman ...
11h
ZME Science on MSNGoogle’s DeepMind builds AI that helps archaeologists piece together Roman writings
A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...
AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.
1d
GlobalData on MSNMicrosoft expands AI team with key Google DeepMind hires
Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.
Discover how AI models from Google and OpenAI outshined human brilliance at the 2025 IMO, and the ethical debates that ...
Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation. President Colin Murdoch revealed the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results